ArticleAnnals of hematology2023

Brazilian experience with caplacizumab in acquired thrombotic thrombocytopenic purpura: outcomes of the expanded access program.

Tiago de Oliveira Boechat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.